Dex Liquidating Co.
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1M | $1.9M | $3.0M | $3.6M | $3.5M | $3.7M |
| Operating income | −$14.6M | −$15.6M | −$18.8M | −$16.5M | −$15.7M | −$13.3M |
| Net income | −$4.5M | −$3.0M | −$19.2M | −$17.0M | −$16.1M | −$13.6M |
| Total assets | $8.9M | $15.7M | $29.3M | $47.6M | $17.8M | $18.1M |
| Total liabilities | $17.3M | $8.4M | $7.2M | $7.4M | $6.8M | $6.8M |
| Equity | −$8.4M | $7.3M | $22.1M | $40.2M | $11.0M | $11.4M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 48.2M | 8.9M | 89.0M | 89.0M | 51.2M | 36.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- −1318.6%
- Net margin
- −405.0%
- Return on equity
- 53.1%
- Return on assets
- −50.5%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 195.1%
- Debt / equity
- —
- Book value / share
- $-0.18
- Revenue growth (YoY)
- −41.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- -95.96distress
- Accruals / assets
- 102.0%high accruals
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 6 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
- Strong return on equity (>15%)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 14, 2018
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2018
- NT 10-Qmissed a reporting deadline ↗May 15, 2018
- NT 10-Qmissed a reporting deadline ↗Feb 15, 2018
- NT 10-Kmissed a reporting deadline ↗Sep 29, 2017
- NT 10-Kmissed a reporting deadline ↗Sep 29, 2016
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureNov 28, 2018
- Bankruptcy or receivershipNov 19, 2018
- Other material eventNov 19, 2018
- Bankruptcy or receivership · Modified shareholder rights · Director / officer changeNov 13, 2018
- Other material eventOct 19, 2018
- Other material eventSep 20, 2018
- Entered a material agreement · Other material eventAug 27, 2018
- Other material eventAug 20, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13GSCHEDULE 13G FOR NOVEMBER 26, 2018Dec 5, 2018
- 15-12GFORM 15-12GNov 28, 2018
- 8-KFORM 8-KNov 28, 2018
- 8-KFORM 8-KNov 19, 2018
- 8-KFORM 8-KNov 19, 2018
- NT 10-QFORM NT 10-QNov 14, 2018
- 8-KFORM 8-KNov 13, 2018
- 8-KFORM 8-KOct 19, 2018
- NT 10-KFORM NT 10-KSep 28, 2018
- 8-KFORM 8-KSep 20, 2018
- 8-KFORM 8-KAug 27, 2018
- 8-KFORM 8-KAug 20, 2018
- 8-KFORM 8-KJul 13, 2018
- 8-KFORM 8-KJun 20, 2018
- EFFECTJun 19, 2018